header logo image


Page 1,076«..1020..1,0751,0761,0771,078..1,0901,100..»

India to tweak definition of blindness to meet WHO stipulation – India Today

March 26th, 2017 4:42 am

By Payal Banerjee

New Delhi, Mar 26 (PTI) The government is set to change a four-decade-old definition of blindness to bring it in line with the WHO criteria and ensure the Indian data on blindness meets the global estimates.

As defined under the National Programme for Control of Blindness (NPCB), a person unable to count fingers from a distance of six metres is categorised as "blind" in India, against the WHOs stipulation of three metres.

"We will bring the definition of blindness at par with the WHOs criteria. Because of the current definition, we project a higher figure of blind people from India at any international forum. Thus India gets presented in a poor light compared to other countries," said Promila Gupta, NPCB Deputy Director General.

Also, she said, the data "we generate under the programme cannot be compared with the global estimates as other countries are following the WHO criteria".

Uniformity in the definition across various regions of the world is a pre-requisite for facilitating collection of population-based data on prevalence of blindness and estimating its global burden, Gupta said.

Further, India has to achieve the goal set by WHO which recommends reducing the blindness prevalence of the country to 0.3 per cent of the total population by 2020.

"The Vision 2020 recommends reducing the prevalence of blindness to 0.3 per cent by the year 2020 to achieve the elimination of avoidable blindness.

"It will be extremely difficult to achieve the WHO goal using the NPCB definition since we will be addressing an extra 4 million individuals, blind due to refractive errors. By adopting the blindness criteria of WHO, India can achieve the goal," said Praveen Vashist, in-charge, Community Ophthalmology at Dr R P Centre for Ophthalmic Sciences at AIIMS.

The Health Ministry is also planning to change the nomenclature of NPCB to the National Programme for Control of Visual Impairment and Blindness.

"The idea is to further strengthen the programme by focusing not only on the blind persons but also those with some kind of visual impairment.

"It urges the member states to strengthen national efforts to prevent avoidable visual impairment through better integration of eye health into national eye health plans and service delivery," Gupta added.

She said India currently has around 12 million blind people against 39 million globally-- which makes India home to one-third of the worlds blind population.

The current definition of blindness was adopted at the time of the inception of the NPCB in 1976.

"The probable reason for keeping 6 meters as cut-off for defining blindness in India was to include economic blindness cases which referred to a level of blindness which prevents an individual to earn his or her wages.

"In contrast, the WHO definition adopts a criteria for blindness that is which hampers the routine social interaction of a person (social blindness)," Gupta said. PTI PLB TIR AAR

See the article here:
India to tweak definition of blindness to meet WHO stipulation - India Today

Read More...

Phoenix Mother: St. Charbel Cured My Blindness – National Catholic Register

March 26th, 2017 4:42 am

Above, Dafne Gutierrez and Father Wissam Akiki, pastor of St. Joseph Maronite Church; below, the relics of St. Charbel visited the parish last year. (StJosephPhoenix.org)

Nation | Mar. 25, 2017

Phoenix Mother: St. Charbel Cured My Blindness

After praying before relics, confession and being blessed with holy oil, Dafne Gutierrez experienced profound healing.

PHOENIX When a Phoenix mother lost her eyesight due to a rare medical condition, she feared she would never be able to see her four children again. But then St. Charbel came to her aid.

Dafne Gutierrez suffered from benign intracranial hypertension (BIH), a condition that causes increased pressure in the brain. In 2012, the increased pressure caused her to lose vision in her right eye. Three years later, in November 2015, the Catholic motherlost sight in her left eye, as well.

Phoenixs local CBS affiliate, KPHO, quoted Gutierrezs plea to God:

For me, I was like, Please God, let me see those faces again. Let me be their mother again. Because I feel like [my kids] were watching me, taking care of me 24/7.

For more than a year, Gutierrez struggled to adjust to her disability, which now included occasional seizures, as well as blindness. Then, in January 2016, when Phoenixs St. Joseph Maronite Church announced that the relics of St. Charbel Makhlouf (also spelled Sharbel) would be visiting the church, Gutierrezs sister encouraged her to visit and to pray for the saints intercession.

Although she is not a member of the Maronite rite, Gutierrez visited the church Jan. 16, prayed before the relics, went to confession and was blessed with holy oil by the pastor, Father Wissam Akiki. Gutierrez recalled that, immediately afterward, her body felt different.

The following morning, she rose and returned to the church for Sunday Mass. Again, she experienced a different sensation.

And early in the morning Jan. 18, Gutierrez awoke with a searing pain in her eyes. She remembers how much they burned. And when her husband turned on the lights, she said the brightness hurt her eyes. She claimed, at 4am, that she could see shadows; but her husband insisted that was impossible because she was blind. He later described what he called an odor of burned meat coming from her nostrils.

According to The Maronite Voice, the newsletter of the Maronite Eparchies of the U.S., That morning she called her ophthalmologist, and she was evaluated the next day. Her exam showed that she was still legally blind, with abnormal optic nerves. Two days later, she saw a different ophthalmologist, and her vision was a perfect 20/20, with completely normal optic nerves. Subsequently, she saw her original ophthalmologist one week later, and her vision was documented to be normal, with completely normal exam.

No Medical Explanation

Dr. Anne Borik, a board-certified internal medicine physician who later testified regarding Gutierrezs healing, was called in by the Church to review the case. Earlier this month, Borik a member of St. Timothys Roman Catholic parish nearby, but who attends St. Joseph Maronite frequently talked by phone with the Register about her findings. She explained that the brain condition Gutierrez suffered from causes the optic nerve to constrict. Once the optic disc the spot at which the optic nerve enters the eyeball is damaged, its too late to fix. Because, when the pressure in the brain reaches high levels, as it did in Gutierrezs case, the optic nerves become strangulated.

Unfortunately, once the blindness occurs, said Borik, its irreversible.

Images of Gutierrezs optic disc revealed significant damage: We have pictures, said Borik, to confirm that the optic disc was chronically atrophied. There was significant swelling, or papilledema.

But after Gutierrezs vision returned, Borik reported, there was no evidence of the aberrations that were evident on earlier images. In the post-healing pictures, Borik said, her optic disc is back to normal. Her vision is completely restored. She has no more seizures. That is why I, as a medical doctor, have no explanation.

A medical committee, led by Borik, undertook a thorough review of Gutierrezs medical records, as well as repeated examinations. The committee wrote, After a thorough physical exam, extensive literature search and review of all medical records, we have no medical explanation and therefore believe this to be a miraculous healing through the intercession of St. Charbel.

Unexpected Healing Strengthens Faith

Borik is enthusiastic about the healing, telling the Register, It has changed my practice! It has changed how I relate to patients. Now, she said, referring to her relationship with those entrusted to her care, prayer is such an important part of what we do.

Father Wissam Akiki, pastor of St. Joseph Maronite Church, had a devotion to St. Charbel (see sidebar below), and he installed a large picture of the saint in the parish shortly after his arrival in 2014. Then, in 2016, he arranged to bring St. Charbels relics to his parish as part of a U.S. tour.

Father Akiki remembers when Gutierrez showed up to venerate the relics. Father Akiki approached her. I heard her confession, he told the Register. We prayed together, and I said to her daughter, Take care of your mom, and your mom is going to see you soon. Then, in only three days, she called the church to report that she could see.

Father Akiki acknowledged that Gutierrezs healing has strengthened the faith and changed the face of St. Joseph Maronite Church. People are coming here to pray, traveling from Germany, Bolivia, Canada, Australia, Jerusalem.

Following the healing, Father Akiki planned to erect a shrine to St. Charbel at his parish, with a two-ton sculpture of the saint cut from a single stone and imported from Lebanon. The shrine will be open seven days a week, 24 hours a day. Father Akiki expectedthat the dedication of the shrine March 26 woulddraw crowds, including Maronite Bishop A. Elias Zaidan, Phoenix Bishop Thomas Olmsted and many local dignitaries.

Bishop Zaidan attributed Gutierrezs recovery to the intercession of St. Charbel. May this healing of the sight of Dafne, he wrote in The Maronite Voice, be an inspiration for all of us to seek the spiritual sight, in order to recognize the will of God in our lives and to act accordingly.

Cristofer Pereyra, director of the Hispanic Office of the Phoenix Diocese, told Fox News that Bishop Olmsted spoke with the doctors and reviewed the case. The bishop wanted to make sure there was no scientific explanation for the miraculous recovery of Dafnes sight, Pereyra reported.

The greatest change, of course, has been for Gutierrez and her children. Since her eyesight was restored, Dafnes life has changed dramatically: She can once again check her children's homework, watch them at play with friends, and manage her household chores without extra assistance.

Her prayer was answered.

Kathy Schiffer writes from Southfield, Michigan.

Who Was St. Charbel?

Born Youssef Antoun Makhlouf in the high mountains of northern Lebanon in 1828, St. Charbel (also spelled Sharbel) was the youngest of five children in a poor but religious family. His baptismal name was Joseph; only when he entered a monastery at the age of 23 was he given the name Charbel, after an early martyr. He studied in seminary and was ordained a priest in 1858. For 16 years, Father Charbel lived with his brother priests; theirs was a communal life of prayer and devotion to God.

In 1875, Father Charbel was granted permission to live a hermits life. In his rugged cabin, for the next 23 years, he practiced mortification and sacrifice often wearing a hair shirt, sleeping on the ground, and eating only one meal a day. The Eucharist was the focus of his life. The holy priest celebrated daily Mass at 11am, spending the morning in preparation and the rest of the day in thanksgiving.

Father Charbel was 70 years old when he suffered a seizure while celebrating Mass. A priest assisting him was forced to pry the Eucharist out of his rigid hands. He never regained consciousness; and eight days later, on Christmas Eve in 1898, Father Charbel died. His body was interred in the ground without a coffin and without embalming, according to the monks custom, dressed in the full habit of the order.

For the next 45 nights, a most unusual event occurred: According to many local townspeople, an extraordinarily bright light appeared above his tomb, lighting the night sky. Finally, after the mysterious light persisted, officials at the monastery petitioned the ecclesiastical authorities for permission to exhume Charbels body. When the grave was opened four months after Charbels death, his body was found to be incorrupt. Twenty-eight years after his death, in 1928, and again in 1950, the grave was reopened, and his body was also found to be without decay.

Numerous medical researchers were permitted to examine the remains, and all confirmed that the saints body was preserved from decay. For 67 years, the body remained intact, even when left outdoors unprotected for an entire summer although it consistently gave off a liquid that had the odor of blood. Finally, though, Charbels body followed the natural course. When the tomb was again opened at the time of his beatification in 1965, it was found to be decayed, except for the skeleton, which was deep red in color.

The inexplicable restoration of Dafne Gutierrezs eyesight is not the first healing credited to St. Charbel. Dr. Anne Borik reported that there have been hundreds perhaps thousands of miracles attributed to the saint.

Pope Francis is said to have a deep devotion to St. Charbel. Last Christmas, Borik reported, the Holy Father asked to have a relic of St. Charbel sewn into the hem of his vestments.

Kathy Schiffer

Read the rest here:
Phoenix Mother: St. Charbel Cured My Blindness - National Catholic Register

Read More...

Brit scientists testing ‘groundbreaking’ therapy that could cure common cause of blindness – The Sun

March 26th, 2017 4:42 am

The treatment is aimed at one of the most common causes of blindness in boys and young men

SCIENTISTS seeking a cure for blindness are testing a groundbreaking gene therapy on British patients.

The clinical trial aims to find a treatment for one of the most common causes of blindness in boys and young men.

Alamy

X-linked retinitis pigmentosa, allows the retinal cells to gradually stop working and eventually die, which prevents the eyes from processing light. There is currently no treatment available for sufferers. The trial, which could feature up to 30 patients, follows success by an Oxford

University team in treating those with another form of hereditary blindness, known as choroideremia.

Last Thursday a 29-year-old man with XLRP became the first patient to undergo the gene therapy procedure at Oxford Eye Hospital.

A virus carries corrective DNA into cells at the back of the eye.

For the treatment to work scientists have to reprogramme a gene called RPGR to make it more stable. The instability of that gene in the retina has previously been a major obstacle to finding a way of tackling the condition.

Prof Robert MacLaren, of Oxford University, said: We have spent many years working out how to develop this gene therapy.

Changing the genetic code is always undertaken with great caution, but the new sequence we are using has proven to be highly effective in our laboratory studies.

View original post here:
Brit scientists testing 'groundbreaking' therapy that could cure common cause of blindness - The Sun

Read More...

Top 6 Everyday Products Using Biotechnology – The Merkle

March 26th, 2017 4:42 am

Biotechnology is a popular trend that can be found in various aspects of our everyday lives. While it is true biotechnology is a very complicated concept to grasp, it is also one of the most promising technologies to be found today. Biotechnology will help our society address some of its greatest challenges moving forward. Below are some very common use cases for biotechnology most people will have come in contact with already.

It is anything but surprising to learn biotechnology has made a big impact on the medical sector over the past few years. Biotechnology, or more specifically, bio-processing, is used to develop new pharmaceuticals which are often difficult to produce due to purity quality control requirements. Some of the more popular biotech pharmaceuticals include Remicade, Rituxan, Prevarn, and Avastin.

Very few consumers give fabrics a second thought, other than to determine whether the material would rub against the skin. Interestingly enough, most fabrics are dyed through a fermentation vat process. Biochemicals are very common in the production of dyes, polyester, and nylon. It is evident there is some form of biotechnology involved in every piece of synthetic clothing we wear today.

Even though biofuel is not as popular as it could be, the concept holds a lot of merit for the future. Biodiesel helps reduce the carbon impact, which is of great importance to the future of our species. To produce biofuel, one needs specific plant-derived sugars which are then fermented using biotechnology to create ethanol. Further advances in the development of biofuel will see the introducing of alternative compoundsto jet fuel.

It may come as a surprise to find out Goodyear Tire is actively exploring the boundaries of biotechnology. Through a partnership with Genencor, the company is researching synthetic rubber created out of mostly renewable raw materials. In doing so, the company hopes to replace the crude oil requirements necessary to produce a single passenger tie.

As unusual as it may sound, some of the foods we consume on a regular basis are a direct result of biotechnology. Most of the products usedin food and [soft] drinks are processed using biochemicals. Sweeteners, flavors and acidity regulators found in nearly every product are just a few examples of how biotechnology is affecting our daily lives. Even the packaging used by supermarkets is made of biochemicals.

It appears very few people are aware of what can be found in alcoholic beverages these days. The production process of alcohol is a clear example of industrial biotechnology. This process involves converting starch to sugar and fermenting the yeast. Both parts are biotechnology in its simplest form. There is a lot more to the beer in a bottle than meets the eye, that much is certain.

If you liked this article, follow us on Twitter @themerklenews and make sure to subscribe to our newsletter to receive the latest bitcoin, cryptocurrency, and technology news.

Read more:
Top 6 Everyday Products Using Biotechnology - The Merkle

Read More...

PUMA BIOTECHNOLOGY, INC. (NASDAQ:PBYI) Files An 8-K Changes in Registrant’s Certifying Accountant – Market Exclusive

March 26th, 2017 4:42 am
PUMA BIOTECHNOLOGY, INC. (NASDAQ:PBYI) Files An 8-K Changes in Registrant's Certifying Accountant
Market Exclusive
Puma Biotechnology, Inc. is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on in-licensing the global development and commercialization rights to over ...

See the original post here:
PUMA BIOTECHNOLOGY, INC. (NASDAQ:PBYI) Files An 8-K Changes in Registrant's Certifying Accountant - Market Exclusive

Read More...

National Nutrition Month: Age-related macular degeneration, rheumatoid arthritis, heart health – Bel Marra Health

March 26th, 2017 4:41 am

Home General Health National Nutrition Month: Age-related macular degeneration, rheumatoid arthritis, heart health

March is National Nutrition Month, so to keep you informed about nutrition, we have compiled a list of our top articles discussing nutrition and related topics including age-related macular degeneration, rheumatoid arthritis, and heart health. Here you will learn about foods that will boost your immune system, help you lose weight, and even save money while doing it. Come and learn how various simple changes to your diet can have great effects on your health and overall well-being.

Its often assumed that eating healthy costs a lot of money, meaning if you cant afford big-name superfoods, you end up buying cheaper fast food to satisfy your hunger. Unfortunately, as you know, not eating well can contribute to various health repercussions.

There are many superfoods out there that health experts have advocated for. But what exactly makes a food a superfood? Well, for starters, these foods are often packed with nutrients that work to promote good health. You receive an ample supply of vitamins and minerals known for supporting overall well-being. As mentioned, though, these foods often come with a hefty price tag, which can make healthy eating practices difficult to follow. Continue reading

Age-related macular degeneration (AMD) is a common occurrence for those over the age of 50, but that doesnt mean you cant try to prevent it. In fact, your diet plays a large role in age-related macular degeneration progression and development, so eating the right foods can help you enjoy a clear view for many years to come.

Age-related macular degeneration is a condition that progresses with age. It begins to affect people over the age of 40 by hindering central vision, which is used for activities such as reading and driving. When central vision begins to deteriorate, completing daily tasks becomes quite difficult. Continue reading

Rheumatoid arthritis management can be achieved through an anti-inflammatory diet and Mediterranean diet in order to reduce inflammation. Nutrition plays a vital role in all of our bodily functions and eating the right foods can mean the difference between good or poor health. Many foods are natural healers, so it should be of no surprise that food can play a role in managing rheumatoid arthritis (RA).

Overall, rheumatoid arthritis patients are recommended to consume a healthy, balanced diet to maintain a healthy weight. Guidelines found in theNutrition and Your Health: Dietary Guidelines for Americans, fourth edition, describe what kind of diet patients with rheumatoid arthritis should stick to. The recommendations suggest eating a variety of foods, balancing healthy eating habits with physical activity, consuming plenty of grains, fruits, and vegetables, sticking to a low-fat diet, which is also low in saturated fat and cholesterol, moderating sugar intake, and drinking alcohol in moderation. Continue reading

A popular method for dieting is to count calories. Recommended daily calories for a sedentary senior male is around 2,000 and 1,600 for females. Of course, this would increase if a person is active. Counting calories seems like a universal way to lose or maintain weight, but its important to keep in mind every person is different inside and out so what may work for one person may not necessarily be effective for another.

Research is now suggesting that we move away from this popular diet trend and instead opt to promote the nutritional value of food. This way of eating has shown to be more effective in reducing illness and cutting down on obesity. Continue reading

Bottles that allow you to infuse water with fruit and vegetables are all the rage right now, and while nutritionists say there is nothing wrong with that, they do want consumers to understand the real value in drinking, paying for and creating your own infusion type drinks.

Infusion enthusiasts in the United Kingdom were recently introduced to a new twist on flavored water. A market called Whole Foods put three stalks of asparagus in large bottles of water and priced them at six dollars each. Store management quickly admitted it was a mistake and the asparagus water sparked new debate over the question: Are flavored waters really any better than regular water? Continue reading

Related Reading:

Osteoarthritis (degenerative arthritis): Causes, symptoms, and treatment

Heart attack symptoms in women over 50: Facts on women and heart disease

Read more:
National Nutrition Month: Age-related macular degeneration, rheumatoid arthritis, heart health - Bel Marra Health

Read More...

Symposium discusses latest and future of stem cell therapy – The Pasadena Star-News

March 26th, 2017 4:40 am

DUARTE>> Dozens of doctors, scientists, businesses and others gathered at City of Hope Thursday for the second California Institute for Regenerative Medicine (CIRM), Alpha Stem Cell Clinics symposium.

CIRM, the states stem cell agency, has developed a network of Alpha Stem Cell Clinics that focus on innovative stem cell-based therapies. The network of three clinics are located at City of Hope, University of California, San Diego, and UCLA/UC Irvine campuses.

The event served as a way for clinics to share their most recent advancements and successes in stem cell therapy clinical trials, and even hear directly from patients who benefited from some of the trials.

We want to review the trials, but we also want to see what other questions we should be asking, said Dr. John Zaia, the Aaron Miller and Edith Miller Chair in Gene Therapy, and director of the Center for Gene Therapy and principal investigator of City of Hopes Alpha Stem Cell Clinic. How will insurance companies charge or pay for these treatments? How do companies plan to develop these treatments? The symposium provides an opportunity to think about these other aspects.

There were also panel speakers who offered more of a motivational talk, such as Pat Furlong, founding president of Parent Project Muscular Dystrophy, discussing how to remove stakeholder barriers to stem cell therapy treatment.

Furlong had to become her and her sons own advocate when they were diagnosed with Duchenne Muscular Dystrophy at a young age. She found there was no standard of care for the disease and no studies or trials in progress to find a treatment, let alone a cure.

Families just didnt know the questions to ask, she said. At the time, few people cared about rare diseases.

After years of no real hope and losing her sons at 15 and 17 years old, with her and her groups persistence, Furlong said there are now 40 companies researching the disease and millions of dollars have gone into research specifically for Duchenne.

City of Hopes Dr. Behnam Badie, chief of neurosurgery and director of the Brain Tumor Program, and Christine Brown, Ph.D., Heritage Provider Network Professor in Immunotherapy and associate director of the T Cell Therapeutics Research Laboratory, discussed their recent successful treatment of a patient with recurrent multifocal glioblastoma using CAR-T cell therapy.

The case study for this unique type of immunotherapy on the most aggressive form of brain cancer was published in the Dec. 29 edition of the New England Journal of Medicine.

Advertisement

In the Phase I clinical trial, the patient, who did not respond to other types of therapy including radiation and even developed tumors in his brain and spinal cord, was treated with his own genetically modified chimeric antigen receptor (CAR) T cells, injected directly into the tumor and through the ventricular system. The patient experienced remission over 8 months.

City of Hope is one of a few cancer centers in the nation offering studies in CAR-T cell therapy, and is the only cancer center investigating CAR-T cells targeting the specific receptors more common in a majority of glioblastomas.

Dr. Badie and Brown noted that working with CIRM has been instrumental in helping them along with their trial, and not just the funding.

You cant create a good trial without studying the product, said Brown. These are expensive trials. We have to treat these patients and understand what is going on.

More:
Symposium discusses latest and future of stem cell therapy - The Pasadena Star-News

Read More...

Erectile dysfunction: Stem cell therapy restores sexual function in phase I trial – Medical News Today

March 26th, 2017 4:40 am

Early results of a clinical trial suggest that stem cell therapy may be a promising treatment for erectile dysfunction, after the procedure was found to restore sexual function in men with the condition.

The stem cell therapy involves injecting the patients' own stem cells - derived from abdominal fat cells - into the erectile tissue of the penis.

Lead researcher Dr. Martha Haahr, of Odense University Hospital in Denmark, and colleagues found that within 6 months of the procedure, 8 of the 21 men treated were able to engage in spontaneous sexual intercourse.

The researchers recently presented their findings at EAU17 - the European Association of Urology's annual conference - held in London in the United Kingdom.

Erectile dysfunction (ED) is a condition whereby a man has difficulties getting or maintaining an erection in order to engage in sexual intercourse.

According to the National Institute of Diabetes and Digestive Kidney Diseases, around 12 percent of men under the age of 60, and 22 percent of men aged between 60 and 69, have ED.

High blood pressure, diabetes, heart disease, chronic kidney disease, and prostate surgery are some of the physical conditions that can cause ED. Psychological issues - such as anxiety, stress, depression, and low self-esteem - can also contribute to ED.

Current treatments for ED include PDE5 inhibitors (such as Viagra), penile implants, and injections. However, Dr. Haahr and team note that all of these therapies can have significant side effects.

As a result, researchers are on the hunt for alternative treatments for ED, and stem cell therapy has emerged as a promising candidate in animal trials.

In their phase I trial, Dr. Haahr and colleagues tested stem cell therapy on 21 men who had ED as a result of undergoing radical prostatectomy for prostate cancer. None of the men had responded to standard medical treatment for ED.

For the stem cell procedure, abdominal fat cells were extracted from each man through liposuction. Stem cells were then isolated from the fat cells and injected into the corpus cavernosum of the penis - the spongy tissue that normally becomes filled with blood during an erection.

Before the stem cell procedure and 6 and 12 months after, the participants' erectile function was assessed using the International Index of Erectile Function (IIEF) questionnaire. An IIEF score of 5-7 represents severe erectile dysfunction, 12-16 is mild to moderate erectile dysfunction, and 22-25 is no erectile dysfunction.

All 21 men saw their erectile function improve with stem cell therapy: their IIEF score increased from 6 prior to treatment to 12 at 6 months after treatment.

Eight of the men reported that they had been able to engage in spontaneous sexual activity 6 months after stem cell therapy, and this outcome remained evident at 12 months after treatment. These men saw their IIEF score rise from 7 to 14 with stem cell therapy.

"What we have done establishes that this technique can lead to men recovering a spontaneous erection - in other words, without the use of other medicines, injections, or implants," says Dr. Haahr.

Although the study findings are preliminary, the team says that they show promise for stem cell therapy as an effective treatment strategy for ED.

"We are the first to use a man's own fat stem cells as a treatment for erectile dysfunction in a clinical trial. The technique has been trialed in animal work, but this is the first time stem cell therapy has allowed patients to recover sufficient erectile function to enable intercourse," says Dr. Haahr.

"We are pleased with the preliminary outcomes, especially as these men had previously seen no effect from traditional medical treatment and continue to have good erectile function after 12 months follow-up, indicating that this might be a long-term solution.

This suggests the possibility of therapeutic options for patients suffering from erectile dysfunction from other causes. But we need to remember that this is a small trial, with no control group. We're still some time away from a clinically available solution."

Dr. Martha Haahr

The researchers are now in the process of initiating a phase II trial to further investigate the safety and efficacy of stem cell therapy for ED.

Learn how eating more fruits could help to lower the risk of ED.

See original here:
Erectile dysfunction: Stem cell therapy restores sexual function in phase I trial - Medical News Today

Read More...

Jesus heals blindness, both physical and spiritual – CatholicPhilly.com

March 24th, 2017 5:44 pm

Msgr. Joseph Prior

By Msgr. Joseph Prior Posted March 24, 2017

(See the readings for the Fourth Sunday of Lent, March 26)

The collect prayer for Sundays liturgy reads: O God, who through your Word reconcile the human race to yourself in a wonderful way, grant, we pray, that with prompt devotion and eager faith the Christian people may hasten toward the solemn celebrations to come. Through our Lord Jesus Christ, your Son, who lives and reigns with you in the unity of the Holy Spirit, one God, for ever and ever. Amen.

This Sunday is known as Laetare Sunday. The term comes from the entrance antiphon: Rejoice, Jerusalem, and all who love her. Be joyful, all who were in mourning; exult and be satisfied at her consoling breast (Isaiah 66:10). In the midst of our observance of Lent we are reminded, as we prepare for the Triduum and Easter, that Christ has triumphed already and we readily recognize the joy of his victory that lasts for all time. The Lenten season helps us to prepare for these celebrations that mark our deliverance from darkness to light, from sin to grace, from death to life.

The readings for the Mass help us in our preparations. We are reminded of Gods saving activity in the life of mankind. We are invited to consider that God does not always act in expected ways. He saving activity supersedes all human expectations.

The first reading comes from the First Book of Samuel and recalls the selection of David as the Lords anointed, who will one day reign as king. He will be a great king, though not without his faults. He will defend Israel from her enemies and strengthen the bonds among the tribes and he will eventually bring peace.

Yet here at the beginning, there are no signs of future greatness. When the Lord sends Samuel to the house of Jesse to find the one, the Lord says: Do not judge from his appearance or from his lofty stature, because I have rejected him. Not as man sees does God see, because man sees the appearance but the Lord looks into the heart.

So Samuel goes and sees the sons. It is not the first-born son, and it is not one of the next six sons who have been gathered. In fact expectations are so low with regard to David that he is not even there. The youngest son is out working in the fields and has to be summoned. When he arrives the Lord says to Samuel: There anoint him, for this is the one!

Jesus, a Son of David through Joseph, likewise was not the obvious one by mans standards. The Pharisees give witness to this attitude in Sundays Gospel reading from the Gospel according to John. In the account of the man born blind, the Pharisees have already determined that it is impossible for Jesus to be doing the Lords work. They determine that Jesus is a sinner because he cured on the Sabbath, thus breaking the Lords law. They refuse to acknowledge that Jesus has delivered the blind man from his blindness.

In their minds it is impossible for Jesus to be the one, for God does not work through sinners. Through their obstinate judgment of Jesus, they are blinded to Gods saving activity among them.

Jesus comes into the world to dispel the darkness of doubt and unbelief. His saving activity is seen in the cure of the man born blind which foreshadows the salvation offered to all.

At the beginning of the account, Jesus is asked about the mans sinfulness. The presumption is that blindness came through sin in this case the sins of his parents since he was born blind. Jesus tells them that physical blindness is not the result of sin. Rather it is this blindness that will allow the glory of God to shine forth in Jesus saving activity.

Jesus tells those disciples: While I am in the world, I am the light of the world. He then goes on to restore sight to the man born blind. The healing is offered, not just for the blind man who will later acknowledge his faith in the Son of Man, but also as a sign for others to see so they too might have faith.

We celebrate the light of the world who is Christ Jesus. The joy is so great that on this Sunday we even use the bright rose-colored vestments to mark it. Lent continues, though, as we journey toward the triduum, the celebration of baptism and the renewal of our own baptismal promises.

The sacred time affords us the opportunity to move from darkness to light, to be healed of our sins and to celebrate worthily the life won for us in Jesus Christ.

***

Msgr. Joseph Prior is pastor of St. John the Evangelist Parish, Morrisville, and a former professor of Sacred Scripture and rector of St. Charles Borromeo Seminary.

PREVIOUS: Readings of the holy Mass Fourth Sunday of Lent

See the original post:
Jesus heals blindness, both physical and spiritual - CatholicPhilly.com

Read More...

MVIT organises three-day national seminar on Biotechnology – Times of India

March 24th, 2017 5:44 pm

BENGALURU: For all Bioscience graduates pursuing BE, BTech, BSc, MSc, MTech and PhD courses, there is good news for their career. The department of Biotechnology at Sir M Visvesvaraya Institute of Tecnology (MVIT) is organising a three day national seminar on Entrepreneurial Opportunities in Biotechnology from March 23 - 25 at its campus. The seminar that is also open to inquisitive parents, energetic alumni, enthusiastic faculty and industry experts is expected to alleviate the many concerns of graduates and their parents regarding their future prospects and career development. HG Nagendra, professor and head of the Biotechnology department, said: "The focus of education is to not only train the students in curriculum defined skillsets but also to guide them towards realising their higher aspirations." The seminar includes invited plenary talks by subject experts, panel discussions, industry-academia interactive sessions, poster sessions, project idea presentations, several stalls and displays. Cash awards will be awarded to those with best presentations and networking at the seminar.

Read the original post:
MVIT organises three-day national seminar on Biotechnology - Times of India

Read More...

7 Surprising Arthritis Symptoms Every Woman Needs To Know – Prevention.com

March 24th, 2017 5:43 pm
7 Surprising Arthritis Symptoms Every Woman Needs To Know
Prevention.com
"Depending on the type of arthritis, if you catch it early your doctor may be able to help you slow its progression," Shea says. Early detection could also give your doc the chance to administer anti-inflammation drugs, or recommend lifestyle changes ...

More here:
7 Surprising Arthritis Symptoms Every Woman Needs To Know - Prevention.com

Read More...

Star names back National Rheumatoid Arthritis Society campaign – Maidenhead Advertiser

March 24th, 2017 5:43 pm

A Strictly Come Dancing judge, a Great British Bake Off winner and two celebrity chefs have backed a new initiative by a Maidenhead-based charity.

Craig Revel Horwood, who has featured on Strictly since 2004, and Michelin-starred chef Tom Kerridge are among those who have teamed up with the National Rheumatoid Arthritis Society (NRAS).

They will be supporting the Time for Tea campaign, which is seeking to raise awareness of Rheumatoid Arthritis (RA) and collect money for NRAS by holding fundraising tea parties.

Revel Horwood said: Rheumatoid Arthritis has had a huge impact on my life, growing up watching my mother struggling on a daily basis to cope with the effects of this disease.

I am delighted to be supporting the NRAS Tea Party - a fun and simple way to support NRAS valuable work and ensure they can continue to be there to help people like my mother.

Francis Quinn, who won the 2013 edition of the Great British Bake Off, and TV cook Lorraine Pascale have also signed up.

NRAS provides help and support for the 690,000 adults with RA in the UK, as well as 12,000 children with JIA (Juvenile Idiopathic Arthritis).

The condition mainly affects the joints of sufferers, but can also cause problems in the heart, eyes and lungs.

The charitys head of fundraising, Michelle Vickers, said: Time for Tea is a great way for people who want to raise money for NRAS and be able to do it in a fun and inclusive way every month.

We love to bring people together and with the rise of baking across the UK this is a fantastic way of raising community spirit.

Whether you know someone with RA, you have RA or you just want to help people who are impacted with the life-altering condition, Time for Tea will help you to make a difference.

Visit http://www.nras.org.uk/tea-party to find out more and apply for a fundraising pack.

Link:
Star names back National Rheumatoid Arthritis Society campaign - Maidenhead Advertiser

Read More...

China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics – Yahoo Finance

March 24th, 2017 2:45 am

NEW YORK, March 23, 2017 /PRNewswire/ -- China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent-making it the diabetes capital of the world.

The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.

China's diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

IMARC's new report"China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics"provides an analytical and statistical insight into the Chinese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.

What we have achieved in this report?

Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics: Focus of the Analysis: Historical, current and future prevalence of diabetes in China Historical, current and future prevalence of type-1 and type-2 diabetes in China Historical, current and future prevalence of diabetes in the urban and rural regions in China Historical, current and future prevalence of diabetes among males and females in China Historical, current and future prevalence of diabetes among various age groups in China Historical, current and future diagnosis rates for diabetes in China Historical, current and future drug treatment rates for diabetes in China

Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics: Focus of the Analysis: Performance of the Oral Antidiabetics market in China Performance of key classes Performance of key players Market outlook

Comprehensive situation analysis of the Chinese Insulin market and its dynamics: Focus of the Analysis: Performance of the Insulin market in China Performance of key classes Performance of key players Market outlook

Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics: Focus of the Analysis: Performance of the diabetes diagnostics market in China Market Segmentation Key players Market outlook Read the full report: http://www.reportlinker.com/p03451748-summary/view-report.html

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/china-diabetes-market-report-patients-prevalence-oral-antidiabetics-insulin-and-diagnostics-300428709.html

Read the original:
China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics - Yahoo Finance

Read More...

Anti-aging peptide recovers fur growth, kidney health in mice – Medical News Today

March 24th, 2017 2:42 am

An anti-aging therapy could be one step closer; in a new study, researchers reveal how a peptide led to the destruction of cells that play a role in aging, reversing fur loss, kidney damage, and frailty in mice.

The research describes how the peptide stops levels of a protein called FOXO4 from increasing in senescent cells, which are cells that lose the ability to replicate and destroy themselves, but which remain metabolically active.

Senescent cells accumulate with age, and studies have shown that they can contribute to the aging process by causing damage to neighboring cells and impairing tissue function.

Previous research has shown that in senescent cells, levels of FOXO4 rise to prevent another protein called p53 from prompting the cells' self-destruction.

By blocking FOXO4 with the peptide, the research team has been able to restore programmed cell death, or apoptosis, in senescent cells.

"Only in senescent cells does this peptide cause cell death," says senior author Peter de Keizer, a researcher of aging at Erasmus University Medical Center in the Netherlands.

"FOXO4 is barely expressed in non-senescent cells, so that makes the peptide interesting, as the FOXO4-p53 interaction is especially relevant to those cells, but not normal cells."

On administering the peptide to fast-aging mice in regular doses, the researchers were able to reverse age-related conditions, such as fur loss and poor kidney health.

The findings were recently published in the journal Cell.

For their study, the researchers tested the peptide on older mice that had aged naturally and mice that had been genetically modified to age rapidly.

Both groups of mice developed characteristics and health problems commonly associated with aging, such as loss of fur, a decline in kidney health, and frailty.

Some of the rodents in each group were given infusions of the peptide three times a week for 10 months, while the remaining mice were monitored as controls.

Both the fast-aging and naturally aged mice saw improvements with peptide treatment, with no apparent side effects.

Within 10 days, the fast-aging mice began to experience fur regrowth. After 3 weeks, the naturally aged mice began to see improvements in fitness, compared with mice that did not receive the peptide.

Additionally, both the fast-aging and naturally aged mice started to demonstrate improvements in kidney function from 1 month after peptide treatment.

The team notes that the effects of peptide treatment were was so strong in fast-aging mice that doses needed to be reduced over the study period.

The researchers say that their findings support previous research showing that targeting senescent cells can help to reverse aging and increase lifespan, though much more research is warranted.

"The common thread I see for the future of anti-aging research is that there are three fronts in which we can improve: the prevention of cellular damage and senescence, safe therapeutic removal of senescent cells, to stimulate stem cells - no matter the strategy - to improve tissue regeneration once senescence is removed," says de Keizer.

He and his colleagues now plan to conduct a clinical trial to assess the safety of the peptide in humans.

Learn how exercise prevents cellular aging by increasing mitochondrial capacity.

More:
Anti-aging peptide recovers fur growth, kidney health in mice - Medical News Today

Read More...

‘Bad luck’ mutations increase cancer risk more than behavior, study says – fox5sandiego.com

March 24th, 2017 2:42 am

The uncrontolled division of cancer cells leads to the carcinogenesis.

The uncrontolled division of cancer cells leads to the carcinogenesis.

For the first time, researchers have estimated what percentage of cancer mutations are due to environmental and lifestyle factors, hereditary factors and random chance. Overall, 66% of the genetic mutations that develop into cancer are caused by simple random errors occurring when cells replace themselves, according to a new study published in the journal Science.

Environmental factors contribute 29% of mutations, while the remaining 5% are inherited, say Cristian Tomasetti and Dr. Bert Vogelstein, both of Johns Hopkins University.

In a previous paper, Tomasetti and Vogelstein asserted that your risk of developing cancer is largely based on random DNA errors that occur when self-renewing cells divide. In their new paper, they offer more detail describing how dumb luck plays a more significant role than either environmental, lifestyle or hereditary factors in causing this disease.

Every time a perfectly normal cell divides, as you all know, it makes several mistakes mutations, explained Vogelstein in a briefing. Now most of the time, these mutations dont do any harm. They occur in junk DNA, genes unrelated to cancer, unimportant places with respect to cancer. Thats the usual situation and thats good luck.

Occasionally, one of these random miscopies will occur in a cancer driving gene.

Thats bad luck, said Vogelstein.

Though this fact may be demoralizing to some people, researchers noted it might bring comfort to people with cancers they worked to prevent or the parents of children with cancer.

Your lifestyle still matters

In a previous research paper published in 2015, Tomasetti and Vogelstein used a mathematical model to first present this idea that cancer risk is strongly correlated with the total number of divisions undergone by normal cells. For 31 cancers, the researchers first estimated the number of stem cells in tissues where disease arose and then they estimated the rate at which these cells divide. Comparing these to incidence of these cancers in the United States, the two researchers found a strong correlation between cell division and lifetime risk of each given cancer.

For their new study, Tomasetti and Vogelstein worked with Lu Li, a doctoral student at Johns Hopkins Bloomberg School of Public Health, to analyze genome sequencing and epidemiologic data from 32 cancer types, including breast and prostate cancers. This time, the research team concluded that nearly two-thirds of mutations in these cancers are attributable to random errors that occur naturally in healthy, dividing cells during DNA replication.

Drilling deeper, they searched 423 international cancer databases to examine data from 69 countries spanning 6 continents, representing 4.8 billion people or two-thirds of the worlds population. Then, as theyd done in their previous study, they estimated stem cell divisions in different human tissues and compared this to lifetime incidence of 17 cancer types.

Once again, their new mathematical model showed a high correlation between cancer incidence and the total number of divisions of normal cells. This time, though, their finding that 66% of all genetic mutations leading to cancer are caused by random errors crossed borders and so ranged across many different potential environmental factors that might lead to cancer.

While this randomness is upsetting, even mutations caused by environmental or lifestyle factors are haphazard, explained Tomasetti.

Take smoking: Cigarette smoking undoubtedly leads to more genetic mutations than might normally happen, yet where the DNA defects occur on a smokers genome is completely accidental. In other words, mutations caused by smoking, just like random mutations, can affect either cancer driving genes or stretches of DNA that are irrelevant to cancer.

Lifestyle factors still matter for cancer prevention.

Just one mutation is not sufficient to cause cancer typically three or more mutations must occur, Tomasetti noted. If, say, your cells miscopy DNA and so cause two random mutations, a third mutation is still needed. Obesity, smoking, lack of exercise and poor eating habits might supply that necessary third gene defect that tips your body into a disease state.

The new study, then, does not let us off the hook: We play a role in protecting our good health.

Paradigm shift

Since the 1970s, the accepted wisdom underlying cancer research was that genomic alterations caused cancer and most of these alterations are mutations, explained Tomasetti. As envisioned by scientists, DNA defects cause the haywire growth of cells which disturb the natural processes of your body.

Naturally, that leaves one fundamental question: What causes these mutations?

Widespread belief suggests the majority of cancers are caused by behavioral and environmental factors, with inherited genetic mutations causing the remainder of cases.

This is the current paradigm and we feel that our new research breaks this paradigm, said Tomasetti. We discovered theres a third factor that actually causes most of the mutations random errors made during normal cell division.

So why was this never appreciated before? It was never measured before and when you measure something you can have a sense of how important that is, said Tomasetti.

In an editorial published alongside the new study, Martin A. Nowak, a professor of mathematics and biology at Harvard University, and Bartlomiej Waclaw, a researcher at University of Edinburgh, wrote that a large portion of the variation in cancer risk among tissues can be explained, in the statistical sense, by the number of stem cell divisions.

An understanding of cancer risk that did not take bad luck into account would be as inappropriate as one that did not take environmental or hereditary factors into account, Nowak and Waclaw wrote.

While Tomasetti and Vogelsteins first paper led to no less than a few hundred papers written in response, their new study appears to be more soothing to the nerves.

Answers for those who did everything right

I was concerned about the last article, because it didnt talk enough about prevention and it left people thinking, Gee youre just destined to get cancer and you cant do anything about it,' said Dr. Otis Brawley, chief medical officer of the American Cancer Society. Brawley, who was not involved in the research said he was much happier with the current paper, even if it doesnt tell me anything I hadnt known for the last 20 years.

Bert Vogelstein is an incredibly well-respected, well-known cancer biologist who published a paper very similar to this you might even call it part one of this paper two years ago, said Brawley, explaining the original paper caused quite a stir because it implied that almost all cancers were not preventable.

And it really upset the anti-smoking people, it upset the folks who are in the nutrition and physical activity for cancer prevention he really upset the prevention crowd, said Brawley, who believes the new paper is generally a better explanation of the original theory.

Keep in mind its a mathematical simulation, its not a clinical trial, but [Vogelstein is] noting that a certain number of cases are due to replication error, DNA replication error, in normal growth, said Brawley. Those are cancers we really cannot do a lot to prevent.

Brawley described counseling a 47-year old woman who said shed done everything right: She ate healthy, exercised, didnt smoke and got yearly mammograms. Despite having a clean mammogram just six months earlier, she was diagnosed with stage 4 breast cancer.

How did this happen to me? she asked Brawley.

The answer is she had a replication error, said Brawley. And the way you think about replication error is DNA is always being copied throughout your body a million times every day, you know, cells die off and cells are replaced. We have mitosis and an important thing in cell duplication or mitosis is DNA is replicated or copied and the DNA is supposed to be copied exactly and occasionally theres a misreplication or miscopying.

Brawley appreciates the fact that Tomasetti and Vogelstein acknowledge the past controversy and make a point in their new paper of addressing prevention and detection.

I think that we need to have a balance between cancer prevention efforts as well as what I would call wise early detection or wise screening efforts, said Brawley.

Theres a tendency in the US to think that every screening test is great. Unfortunately there are screening tests that actually cause more harm than good, said Brawley.

In the 1960s and 1970s, we stopped doing chest X-ray screening for lung cancer because, after 20 years of doing it, we finally got around to doing an assessment and we found the death rates were higher in the screened versus the unscreened group, said Brawley. The reason? When a patients chest X-ray was found to be abnormal, the follow-up biopsy might cause a collapsed lung or heart attack, he explained.

We still have huge debates whether theres a benefit to prostate cancer screening. There, the benefit might be to a subset of men and not to all men thats an unknown, thats a question mark, said Brawley.

When it comes to mammography screening, thats something all of us believes saves lives but its not perfect, said Brawley.

The best studies that we have show that mammography reduces risk of death by 30%, said Brawley. That means if you have a group of women who habitually get screened, get good high quality screening, mammography is not going to help 70%.

According to Vogelstein, the new study is important for two reasons.

We hope this research offers comfort to the literally millions of patients who have developed cancer but have led near perfect lifestyles, said Vogelstein. Non-smokers who have avoided the sun, these cancer patients eat healthy diets, exercised and done everything to prevent cancer. But they still get it, said Vogelstein.

Its important, especially for parents of children who have cancer, that people understand the root causes of cancer.

The first thing someone looking on the web would see is cancer is caused by environment or heredity, said Vogelstein. When it comes to the parent of a child with cancer, they think they either transmitted a bad gene or exposed their child to an environmental agent that caused disease.

This causes a tremendous amount of guilt, said Vogelstein, who is also a pediatrician and has seen such cases. We dont need to add guilt to an already tragic situation.

The second reason the study is important is because cancer will strike about 1.6 million people in the United States this year. And it will kill 600,000 of us, said Vogelstein. We need a completely new strategy.

He hopes new awareness of these random mutations will inspire many scientists to devote their efforts to various strategies to limit the damage that these internal enemies do.

The first step is simply recognizing these enemies exist, said Vogelstein.

See original here:
'Bad luck' mutations increase cancer risk more than behavior, study says - fox5sandiego.com

Read More...

Scientists Spot Gene for Rare Disorder Causing Deafness, Blindness – Montana Standard

March 24th, 2017 2:42 am

THURSDAY, March 23, 2017 (HealthDay News) -- Researchers say they have found the genetic cause of a rare disorder that causes children to be born with deafness, blindness, albinism and fragile bones.

The syndrome is called COMMAD. It occurs when children inherit two mutations -- one from each parent -- of a gene called MITF. Each parent is also deaf due to another rare genetic disorder called Waardenburg syndrome 2A.

Further research is needed to learn more about the role of MITF during early development and how mutations in this gene result in the development of Waardenburg 2A and COMMAD, said researchers from the U.S. National Eye Institute (NEI).

COMMAD stands for the names of a number of conditions that affect people with this disorder. It includes missing tissue around the eye; abnormally dense bones prone to fracture; small or abnormally formed eyes; an abnormally large head; albinism (lack of melanin in the skin, eyes and hair), and deafness.

Identifying the genetic cause of COMMAD is important because deaf people commonly choose to marry other deaf persons. People who are deaf may not know that their deafness is associated with Waardenburg 2A, the researchers explained.

Deaf couples may want to consider genetic counseling prior to conceiving a child. If both potential parents have Waardenburg 2A, they risk passing mutated versions of MITF to their children, who would then have COMMAD, study lead author Dr. Brian Brooks said in a NEI news release.

Brooks is chief of the NEI's Pediatric, Developmental, and Genetic Ophthalmology section.

The study describes two unrelated cases of children born with COMMAD who inherited the two mutations of MITF from their parents.

Most people who are born deaf don't have Waardenburg 2A. Along with hearing loss, people with the syndrome have premature graying of the hair, blue eyes, fair skin and sometimes vision problems, the researchers said.

The study was published recently in the American Journal of Human Genetics.

See original here:
Scientists Spot Gene for Rare Disorder Causing Deafness, Blindness - Montana Standard

Read More...

Could the Tiny Zebrafish Teach Us to Cure Blindness? – Smithsonian

March 24th, 2017 2:42 am

Zebrafish are only a few centimeters long, but theyve got some supersized powers. When their hearts or brains are damaged, they regenerate. When their fins are cut off, they grow back. When they are blinded, they can regain the ability to see.

Its this last ability thats the subject of some potentially groundbreaking new research. Vanderbilt scientists may have discovered the key to zebrafish retina regeneration. If the process can be replicated in humans, it stands to power new treatments for blindness caused by retinal disease and injury.

As I learned more and more about how zebrafish are capable of regenerating most tissues and organs, I was intrigued, especially with the fact that the zebrafish retina can be damaged to cause blindness yet it only takes about three to four weeks before vision is restored, says James Patton, the biological sciences professor at Vanderbilt who directed the research.

Zebrafish, a freshwater minnow named for their characteristic stripes, havelong been a popular test subjectfor researchers. They breed easily in captivity, grow quickly, and as babies are completely transparent, which makes it easy to study their organs. Then there are their regenerative abilities. As they share 70 percent of humans' genetic code, its often possible to use them to study human genetic traits and diseases.

The structure and cell types of zebrafish retinas are almost identical to those of humans. Each contain three layers of nerve cells: light-detecting photoreceptors, signal-integrating horizontal cells, and ganglion cells that pass visual information on to the brain.

So I became even more intrigued as to why humans cannot regenerate damaged retinas and fish can, Patton says.

Retinal damage is behind many of theleading causes of blindnessin the developed world. These causes includemacular degeneration, an often age-related disease in which part of the retina becomes damaged, causing blurring and blank spots in vision; diabetic retinopathy, where diabetes damages the blood vessels in the retina; andretinitis pigmentosa, a genetic condition causing degeneration of the retinas rod photoreceptor cells. Since human retinas do not regenerate, any retinal damage caused by disease or injury is permanent.

Patton and his team became curious about how, exactly, zebrafish retina regeneration is initiated. Previous studies have suggested that growth factors secreted by dying photoreceptors in the fishes eyes might start the process, sparking stem cells in the eyes to begin dedifferentiating (going back to an earlier developmental stage) and then differentiating into new retina cells. But Mahesh Rao, one of Pattons graduate students, got the idea to look at the neurotransmitter GABA, a chemical messenger in the brain that reduces the activity of neurons, noting that GABA had been found to control stem cell activity in mice brains.

The team tested Raos idea by blinding zebrafishthis can be done by putting them in darkness for a few days, then exposing them to bright lightthen giving them GABA-stimulating drugs. They also gave GABA-lowering drugs to normally sighted zebrafish. They found that the blind fish given GABA-stimulating drugs could not regenerate their retinas normally, while the normal fish with lowered GABA levels began regenerating their retinas. This suggested that it was, indeed, a lowered concentration of GABA that started the retina regeneration process.

The findings were published this month in the journalStem Cell Reports.

We hope to use thefishmodel to understand the factors and mechanisms regulating retina regeneration in the hope that we can apply lessons learned to humans, Patton says.

The team is beginning to test the GABA theory on mice. If that works, it will be on to human trials, testing whether GABA inhibitors can stimulate retina regeneration.

If the research does indeed prove successful in humans, some of thenearly 40 million blind people worldwidemay one day have a tiny, striped fish to thank.

Like this article? SIGN UP for our newsletter

See the original post:
Could the Tiny Zebrafish Teach Us to Cure Blindness? - Smithsonian

Read More...

Patient prepared for blindness while waiting two years for operation – Stuff.co.nz

March 24th, 2017 2:42 am

TERESA RAMSEY

Last updated16:23, March 24 2017

Supplied

Allen Taylor with 200 life size cut-outs of health workers during the New Zealand Public Service Association's health underfunding roadshow outside Thames Hospital.

Allen Taylor was waiting so long for a cataract operation, he came close to losinghis sight.

Born cross-eyed, the Waihi man was already blind in one eye after a botched eye operation when he was 3yearsold.

So when he was told by his optometrist that he needed a cataract operation on his good eye, he was keen to get it done.

However, it took two years on the waiting list before he had the operation at Waikato Hospital last year.

"I was told by my optometrist that if I didn't have anything done shortly, I could go blind," he said.

"I was really worried. When I was waiting, I sort of got used to the idea that I could be blind."

Taylor, 82, said hospital waiting lists shouldn't be so long.

He had friends whose health had deteriorated while on long waiting lists for vital operations, he said.

"It's been going on for a long time but nobody seems to do anything."

Taylor came to Thames Hospital on March 22 to offer his support for the New Zealand Public Service Association's Health Underfunding Roadshow.

The nationwide campaign travelled to 38 towns across the country to raise awareness about health underfunding.

The events included local stories and 200 life size cut-outs of health workers missing due to underfunding.

New Zealand Nurses Organisation industrial advisor Lesley Harry said underfunding was now affecting patient safety.

"Poor access to care, care rationing, health worker burnout and strained infrastructure are now common,"she said.

"The 2016Budget made it clear that the government was not properly assessing current or future funding needs."

Campaign Organiser Simon Oosterman said Thames Hospital hadthe same issues with workload, staffing and funding as the national survey results.

According to a recentYesWeCare.nz survey of 6000 health workers, nine out of 10 people working in health say they don't have enough staff or resources.

The survey results also showed 82 per cent of health workers thoughtthe government's current level of health funding was affecting their workload and work pressure.

YesWeCare.nz is a new community/health workforce coalition for better health funding and includes 83,000 Kiwis working in health, their unions, ActionStation and the People's MentalHealth Review.

-Stuff

Visit link:
Patient prepared for blindness while waiting two years for operation - Stuff.co.nz

Read More...

Field of biotechnology is ever expanding and evolving – BSI bureau (press release)

March 24th, 2017 2:42 am

Dr Kalpana Joshi shares her thoughts with BioSpectrum on current biotech education and the academia-industry gap

Dr Kalpana Joshi is Professor and Head of the Department of Biotechnology at Sinhgad College of Engineering (SCOE). The institute is affiliated to Savitribai Phule Pune University (SPPU) and recognised by All India Council for Technical Education (AICTE), New Delhi. Recently, SCOE has received NAAC "A" Grade. BTech Biotechnology course run by the department is first AICTE approved course in SPPU. Dr Joshi completed her doctorate in molecular biology from National Chemical Laboratory. She headed in-vitro biology group at Pharma R and D, besides giving consultancy to pharma companies like Glenmark, Matrix, Hyderabad and Orchids, Chennai. The SCOE department has a team of faculty with expertise in fermentation engineering, biochemical engineering, pharma biotechnology, biochemistry, analytical chemistry and microbiology. Faculty is active in fetching grants for research, patents and publications. Dr Joshi shares her thoughts with BioSpectrum on current biotech education and the academia-industry gap

Do you think biotech schools are teaching what industry needs?

Field of biotechnology is ever expanding and evolving. Pharma companies have diversified into production and business of biotherapeutics, vaccines and immunologicals, and molecular diagnostics. Industries such as agri-biotech, dairy biotech, food biotech are coming up and have specific requirement of skilled manpower. I feel giving hard core fundamental knowledge of the subjects and skill development are essential to meet industry requirement.

Specific requirements of industry when it comes to biotech education?

Industry requires experienced and trained manpower. There is no time for training in companies. I remember my former boss used to tell me Kalpana this is not university for training. Take someone who would work from the next day.' Biotech schools need to develop necessary laboratory skills and strong basics.

Where is the gap according to you?

As a manager in drug discovery R&D of top pharma company, I used to interview candidates from renowned biotech schools in India. Major observation was students lacked practical skills and basic knowledge of fundamental subjects like microbiology, immunology, molecular biology, biochemistry etc. We at SCOE decided to focus on developing strong knowledge and skills in three pillars of biotechnology namely microbiology, biochemistry, and molecular biology with blend of engineering fundamentals like mass transfer, heat transfer, unit operations, plant design and process development. We have created excellent facilities so that students get to handle top brand equipment like PCR, HPLC, Lyophiliser, fermenters, microfiltrations and develop practical skills in molecular biology, animal tissue culture and data analysis softwares. Gap is at many places. I can give examples. Students use graph papers to plot graphs. We need to train them to use Excel to analyse data and plot graphs using softwares like Prism and SPSS normally used by industries

What do you do to bridge the skill gap if it exists?

At Sinhgad Institutes, we have state-of-the-art laboratories where students are trained for developing practical skills in microbiology, enzymology, molecular biology, fermentations and reaction engineering. We also teach them computation and statistics. Students work on projects and develop skills in at least one technique such as PCR, HPLC or cell culture. They are trained to be analytical, logical and develop problem solving capacity. Students are encouraged to do industry internships and projects in collaboration with companies and national laboratories.

What has been the investment in student training?

We have invested in infrastructure, facilities, equipment and faculty. Faculty members are PhD/ MTechs from renowned institutes like NCL, IITs, ICTs with industry exposure. If faculty does not know what is happening in the industry then it is difficult to percolate it to students. We ensure that faculty gets exposure to industry and maintain interactions with industry experts

Link:
Field of biotechnology is ever expanding and evolving - BSI bureau (press release)

Read More...

CEEB 2017: Applications released for MSc, MTech Biotechnology courses, check here – The Indian Express

March 24th, 2017 2:42 am

By: Express Web Desk | New Delhi | Published:March 24, 2017 12:07 pm CEEB 2017: The details of the course under each university is provided in three prospectus available on the official website

CEEB 2017: The Jawaharlal Nehru University (JNU), Delhi has announced that it will hold The Combined Entrance Examination (CEEB) 2017 for MSc in Biology, MSc in Agricultural Biotechnology and MTech in Biotechnology will be held on May 19, 2017. Candidates who are interested in the courses can apply online from JNUs official website.

The exam is being held by JNU on behalf of 14 universities that offer Agricultural Biotechnology, 32 that offer Biotechnology and six institutes offering MTech in Biotechnology. The details of the course under each university is provided in three prospectus available on the official website along with the fees to be paid at the time of admission. Candidates can also check the eligibility requirements for each college provided in the prospectus.

Steps to apply for CEEB 2017:

Go to the official website for JNU (jnu.ac.in).

Click on the admissions tab on the home page.

Click on the notification Combined Entrance Examination for Biotechnology Programmes [ CEEB ] Prospectus 2017-18 and read the prospectus provided for each course. Make sure to check all details before proceeding.

On the admissions page, click on Apply online and follow the link for CEEB.

Read the instructions carefully and click on I Accept Apply Online.

Fill in the details in the fields provided and click on Register.

Download a copy of the application form for further reference.

For more stories on CEEB 2017, click here

For all the latest Education News, download Indian Express App now

The Indian Express Online Media Pvt Ltd

Read the original here:
CEEB 2017: Applications released for MSc, MTech Biotechnology courses, check here - The Indian Express

Read More...

Page 1,076«..1020..1,0751,0761,0771,078..1,0901,100..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick